Monitoring study with electronic patient-reported outcome for advanced soft tissue sarcoma case during the administration of anti-tumoral drugs -JMOG066-

Monitoring study with electronic patient-reported outcome for advanced soft tissue sarcoma case during the administration of anti-tumoral drugs -JMOG066- - ePRO monitoring for advanced soft tissue sarcoma undergoing anti-tumoral drugs

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050495

Enrollment

150

Registered

2023-03-31

Start date

2023-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced soft tissue sarcoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients undergoing or scheduled to undergo second or subsequent drug therapy for metastatic or unresectable advanced soft tissue sarcoma 2) Patients who have given their consent to participate in the study via electronic manner 3) Those age 20 years or older at the time the consent is obtained 4) Patients with a histopathological diagnosis of soft tissue sarcoma at any of the following: primary, metastatic, or recurrent site 5) The primary lesion is clinically or radiologically determined to be originated from extremity or trunk wall

Exclusion criteria

Exclusion criteria: 1) Patients who have difficulty in answering ePRO due to either dementia, psychiatric disorder, or others 2) Patients that the principal investigator judged incorporation into research is inappropriate

Design outcomes

Primary

Measure	Time frame
time to treatment failure	—

Secondary

Measure	Time frame
overall survival, progression free survival, patient compliance in completing ePRO	—

Countries

Japan

Contacts

Public ContactShunichi Toki

Tokushima University Department of Orthopedics

toki830926@gmail.com0886337240

Outcome results